Chimerix Appoints Timothy Trost SVP, CFO
Chimerix, a pharmaceutical company developing orally-available antiviral therapeutics, has hired Timothy Trost as senior vice president (SVP), chief financial officer (CFO). Trost brings to Chimerix more than 30 years of experience working in the financial field, combining strong executive management skills with an extensive financial background. In this newly-created position, he will be responsible for overseeing the company’s financial operations, reporting to Kenneth Moch, Chimerix’s president and chief executive officer (CEO).
Prior to joining Chimerix, Trost was vice president and CFO at Argos Therapeutics, a venture-backed immunotherapy company. Previously, he was SVP and CFO at InteCardia, a venture-backed cardiac imaging company. While at InteCardia, Trost played a key role in negotiating and executing the sale of the company to Syncor International Corporation. Prior to InteCardia, he served as executive vice president (EVP) and CFO of Coastal Physician Group, a contract provider of emergency room physicians, having joined the company as vice president of corporate development.
He also held the positions of vice president of finance at Morganite North America, and senior manager at Price Waterhouse. Trost holds a BS in Accounting from the University of Illinois at Urbana-Champaign and is a certified public accountant (CPA).